Table 3. Descriptive Data for Primary and Secondary Outcomes Over Assessment Points.
| Month, Group | Score, Mean (SD) | |||
|---|---|---|---|---|
| PHQ-9 | GAD-7 | SF-12 MCS | SF-12 PCS | |
| Intervention Period | ||||
| 0 | ||||
| UDC only (n = 230) | 7.29 (1.53) | 6.20 (3.28) | 34.22 (8.63) | 51.77 (9.61) |
| MMB plus UDC (n = 230) | 7.20 (1.41) | 6.51 (3.15) | 34.27 (7.92) | 51.03 (9.88) |
| 0.5 | ||||
| UDC only (n = 204) | 7.45 (3.28) | NA | NA | NA |
| MMB plus UDC (n = 205) | 6.44 (3.15) | NA | NA | NA |
| 1.0 | ||||
| UDC only (n = 202) | 6.77 (3.58) | NA | NA | NA |
| MMB plus UDC (n = 190) | 5.49 (2.99) | NA | NA | NA |
| 1.5 | ||||
| UDC only (n = 211) | 7.68 (4.08) | NA | NA | NA |
| MMB plus UDC (n = 181) | 5.90 (3.57) | NA | NA | NA |
| 2.0 | ||||
| UDC only (n = 194) | 6.60 (3.59) | NA | NA | NA |
| MMB plus UDC (n = 172) | 4.98 (3.37) | NA | NA | NA |
| 2.5 | ||||
| UDC only (n = 194) | 6.09 (3.53) | NA | NA | NA |
| MMB plus UDC (n = 172) | 4.48 (3.19) | NA | NA | NA |
| 3.0 | ||||
| UDC only (n = 198) | 7.40 (4.27) | 5.41 (3.75) | 38.46 (10.34) | 49.81 (9.55) |
| MMB plus UDC (n = 164) | 5.19 (3.69) | 3.71 (2.98) | 44.10 (9.87) | 49.87 (9.93) |
| End of Active Treatment | ||||
| 4 | ||||
| UDC only (n = 193) | 6.48 (4.09) | NA | NA | NA |
| MMB plus UDC (n = 157) | 4.39 (3.07) | 4.43 (3.94)a | NA | NA |
| 5 | ||||
| UDC only (n = 191) | 6.22 (3.84) | NA | NA | NA |
| MMB plus UDC (n = 160) | 4.62 (3.59) | NA | NA | NA |
| 6 | ||||
| UDC only (n = 191) | 6.16 (3.96) | 5.25 (3.90) | NA | NA |
| MMB plus UDC (n = 158) | 4.70 (3.55) | 4.22 (3.48) | NA | NA |
| 7 | ||||
| UDC only (n = 189) | 6.24 (4.13) | NA | NA | NA |
| MMB plus UDC (n = 158) | 4.36 (3.42) | NA | NA | NA |
| 8 | ||||
| UDC only (n = 191) | 5.89 (3.86) | NA | NA | NA |
| MMB plus UDC (n = 161) | 3.90 (3.17) | NA | NA | NA |
| 9 | ||||
| UDC only (n = 191) | 6.30 (4.23) | 4.96 (3.85) | NA | NA |
| MMB plus UDC (n = 156) | 4.65 (4.11) | 3.89 (3.99) | NA | NA |
| 10 | ||||
| UDC only (n = 181) | 5.95 (4.12) | NA | NA | NA |
| MMB plus UDC (n = 155) | 4.15 (3.66) | NA | NA | NA |
| 11 | ||||
| UDC only (n = 182) | 5.44 (3.56) | NA | NA | NA |
| MMB plus UDC (n = 154) | 4.20 (3.71) | NA | NA | NA |
| 12 | ||||
| UDC only (n = 184) | 5.57 (3.79) | 4.74 (3.77) | NA | NA |
| MMB plus UDC (n = 151) | 4.83 (3.74) | 4.03 (3.80) | NA | NA |
| 13 | ||||
| UDC only (n = 184) | 5.48 (3.82) | NA | NA | NA |
| MMB plus UDC (n = 157) | 4.30 (3.47) | NA | NA | NA |
| 14 | ||||
| UDC only (n = 181) | 5.16 (3.57) | NA | NA | NA |
| MMB plus UDC (n = 155) | 4.01 (3.52) | NA | NA | NA |
| 15 | ||||
| UDC only (n = 176) | 7.06 (4.76) | 4.92 (4.23) | 39.64 (11.93) | 49.58 (9.82) |
| MMB plus UDC (n = 154) | 5.10 (4.19) | 3.49 (3.21) | 44.37 (10.51) | 50.34 (9.29) |
Abbreviations: GADS-7 indicates Generalized Anxiety Disorder–7; MCS, mental component summary; MMB, Mindful Mood Balance; NA, not applicable; PCS, physical component summary; PHQ-9, Patient Health Questionnaire–9; SF-12, 12-Item Short Form Survey; UDC, usual depression care.
a
Patients assigned MMB plus UDC (n = 58) were assessed using the GAD-7 at month 4.